Vorapaxar for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction

Vorapaxar for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction
Country
Agency
Status
Link
Details on adaptation process
Contact information
Croatia
AAZ
2015
Summary of information from the report for decision makers
Mirjana Huic (Mirjana.Huic@aaz.hr)
This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.